On Monday, Brixmor Property Group Inc (NYSE:BRX)’s shares inclined 1.27% to $24.78.
Brixmor Property Group Inc. (BRX) declared that its operating partnership, Brixmor Operating Partnership LP (the “Operating Partnership”), priced its formerly declared offering of $500 million aggregate principal amount of 3.875% Senior Notes due 2022 (the “Notes”). The Notes will be issued at 99.223% of par value with a coupon of 3.875%. Interest on the Notes is payable semi-annually on February 15 and August 15 of each year, commencing February 15, 2016. The Notes will mature on August 15, 2022. The offering is predictable to close on August 10, 2015, subject to customary closing conditions.
The Operating Partnership anticipates to use all or a portion of the net proceeds from this offering to refinance maturing indebtedness and for general corporate purposes. Deutsche Bank Securities Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and RBC Capital Markets, LLC are acting as joint book-running managers for the offering.
Brixmor Property Group Inc. owns and operates various grocery-anchored community and neighborhood shopping centers in the United States. As of March 31, 2013, the company owned interests in 532 community and neighborhood shopping centers comprising 526 wholly owned community and neighborhood shopping centers; and 6 community and neighborhood shopping centers held through unconsolidated real estate joint ventures. Brixmor Property Group Inc. was formerly known as CENTRO SUPER RESIDUAL HOLDING 2 LLC.
At the end of Monday s trade, Nu Skin Enterprises, Inc. (NYSE:NUS)‘s shares dipped -1.06% to $39.23.
Nu Skin Enterprises, Inc. (NUS) will release second-quarter 2015 results after the market closes on Thursday, Aug. 6. The Nu Skin administration team will host a conference call with the investment community later that same day startning at 5 p.m. (EDT). During the call, participants will hear administration talk about past results and forthcoming business initiatives.
Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex brands worldwide. The company offers skin-care systems and treatment products, such as ageLOC Spa systems, ageLOC Tru Face Essence Ultra anti-aging skin care serum, and ageLOC Transformation anti-aging skin care system, in addition to other cosmetic, personal care, and hair care products.
Edwards Lifesciences Corp (NYSE:EW), ended its Monday’s trading session with -0.78% loss, and closed at $150.97.
Edwards Lifesciences Corporation (EW), the global leader in the science of heart valves and hemodynamic monitoring, is planned to present at the Canaccord Genuity 35th Annual Growth Conference at the InterContinental Boston on Wednesday, August 12, 2015.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
